Latest From Biotech Now

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Jim Greenwood

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. Greenwood’s letter discusses the problems that expanded use of specialty tier cost-sharing by the insurance industry are posing for patients, limiting their access to lifesaving therapies and cures. Breakthrough treatments cost billions of dollars, and investors will only take on such risks if they can expect a reasonable return on their investment. The full text of the letter is below: To Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

European Union Lags Well Behind the U.S. in Innovation

admin-ajax

There are many different explanations for the euro crisis: poor fiscal management, loose banking regulation, etc…But one major contributor to Europe’s problems that continues to hold back economies today is a lack of innovation, reported Simon Nixon of The Wall Street Journal. The European Commission’s own “Innovation Scorecard” shows that on almost every measure of innovation, the European Union lags well behind the U.S. and on some measures now lags parts of Asia, while differences between EU Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

LanzaTech CEO Holmgren Selected to receive the 2015 BIO Rosalind Franklin Award

admin-ajax (2)

BIO announced today that Dr. Jennifer Holmgren, Chief Executive Officer of the innovative carbon recycling company LanzaTech, has been selected by a committee of her peers to be the recipient of the 2015 BIO Rosalind Franklin Award. The Rosalind Franklin Award was established by BIO to honor an outstanding woman in the field of industrial biotechnology. ”To be honored in this way is incredibly humbling for me,” said Dr. Holmgren. “Throughout my career, I’ve been Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Tick Size Pilot Program: A Few Pennies Make a Big Difference

72263479

Earlier this week, the Securities and Exchange Commission (SEC) approved a tick size pilot program that will begin next year. We issued this statement, praising the SEC for finalizing this program, which could improve liquidity and enhance capital formation for emerging biotech companies. Under current SEC rules, all securities on the public market are priced in $0.01 increments known as “tick sizes.” The switch to the standard tick size of a penny was enacted in 2000 Read More >

Business and Investments, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Give Your Mom a Color-Changing Petunia for Mother’s Day!

RevoBioengineering

Nikolai Braun and Keira Havens of Revolution Bioengineering have figured out a way to genetically engineer certain flowers to cause them to transition from one color to another. Together, they’ve created a new breed of petunia that can change from white to red, and back again, whenever you want. Here is how the science behind the color-changing flower works: “Most flower color is the result of anthocyanins, small molecules naturally produced in large quantities by a biosynthetic pathway. In Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,